TISSUE POLYPEPTIDE ANTIGEN IN BREAST-CANCER CYTOSOL - A NEW EFFECTIVE PROGNOSTIC INDICATOR

被引:11
作者
GION, M
MIONE, R
PAPPAGALLO, GL
GATTI, C
NASCIMBEN, O
BRANDES, A
VINANTE, O
BRUSCAGNIN, G
机构
[1] GEN REG HOSP,CTR STUDY BIOCHEM MARKERS MALIGNANCY,VENICE,ITALY
[2] PF CALVI HOSP,CTR ONCOL,NOALE,ITALY
[3] GEN REG HOSP,DIV MED ONCOL,PADUA,ITALY
[4] UMBERTO 1 HOSP,CTR ONCOL,DIV RADIOTHERAPY,MESTRE,ITALY
关键词
D O I
10.1016/0959-8049(93)90578-4
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Since 1982 we have been evaluating oestrogen and progesterone receptors (PgR), cathepsin D and the cytosolic levels of the tumour marker, tissue polypeptide antigen (TPA), in 257 patients radically resected for breast cancer (follow-up 24-81 months). TPA was measured by an immunoradiometric assay previously validated for cytosol. No significant associations were found between cytosolic TPA and age, tumour size, lymph-node status, receptor status and cathepsin D. TPA+ cases showed a significantly longer disease-free survival (DFS) and overall survival (OS) than TPA-patients (log-rank P < 0.0001). The prognostic value of cytosolic TPA was also demonstrated after stratification by nodal status, PgR and cathepsin D. The prognostic value of TPA was independent of the other prognostic indicators, being the most powerful among the evaluated indices (Cox multivariate analysis: chi2 15.5 for DFS, 11.4 for OS). We conclude that cytosolic TPA is a powerful additional prognostic factor in primary breast cancer. Its prognostic role should therefore be extensively evaluated.
引用
收藏
页码:66 / 69
页数:4
相关论文
共 32 条
[1]  
BIRKMEYER GD, 1986, J TUMOR MARKER ONCOL, V1, P37
[2]  
BJORKLUND B, 1980, TUMORDIAGNOSTIK, V1, P9
[3]   HISTOLOGICAL GRADING AND PROGNOSIS IN BREAST CANCER - A STUDY OF 1409 CASES OF WHICH 359 HAVE BEEN FOLLOWED FOR 15 YEARS [J].
BLOOM, HJG ;
RICHARDSON, WW .
BRITISH JOURNAL OF CANCER, 1957, 11 (03) :359-&
[4]  
CARTER CL, 1989, CANCER-AM CANCER SOC, V63, P181, DOI 10.1002/1097-0142(19890101)63:1<181::AID-CNCR2820630129>3.0.CO
[5]  
2-H
[6]  
COX DR, 1972, J R STAT SOC B, V34, P187
[7]   IMMUNOCYTOCHEMICAL STAINING OF BREAST-CARCINOMA WITH THE MONOCLONAL-ANTIBODY NCRC-11 - A NEW PROGNOSTIC INDICATOR [J].
ELLIS, IO ;
HINTON, CP ;
MACNAY, J ;
ELSTON, CW ;
ROBINS, A ;
OWAINATI, AARS ;
BLAMEY, RW ;
BALDWIN, RW ;
FERRY, B .
BMJ-BRITISH MEDICAL JOURNAL, 1985, 290 (6472) :881-883
[8]  
FALLENIUS AG, 1988, CANCER, V62, P331, DOI 10.1002/1097-0142(19880715)62:2<331::AID-CNCR2820620218>3.0.CO
[9]  
2-8
[10]  
FISHER ER, 1980, CANCER, V46, P908, DOI 10.1002/1097-0142(19800815)46:4+<908::AID-CNCR2820461310>3.0.CO